G. Karacetin Et Al. , "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders," European Journal of Psychiatry , vol.36, no.1, pp.26-34, 2022
Karacetin, G. Et Al. 2022. BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders. European Journal of Psychiatry , vol.36, no.1 , 26-34.
Karacetin, G., Bayoglu, B., Eseroglu Soylemez, T., Topal, M., Bulanik Koc, E., Tekden, M., ... Ermis, C.(2022). BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders. European Journal of Psychiatry , vol.36, no.1, 26-34.
Karacetin, G. Et Al. "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders," European Journal of Psychiatry , vol.36, no.1, 26-34, 2022
Karacetin, G. Et Al. "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders." European Journal of Psychiatry , vol.36, no.1, pp.26-34, 2022
Karacetin, G. Et Al. (2022) . "BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders." European Journal of Psychiatry , vol.36, no.1, pp.26-34.
@article{article, author={G. Karacetin Et Al. }, title={BDNF Val66Met polymorphism is associated with negative symptoms in early-onset schizophrenia spectrum and other psychotic disorders}, journal={European Journal of Psychiatry}, year=2022, pages={26-34} }